Literature DB >> 2538185

The failure of endothelin to displace bound, radioactively-labelled, calcium antagonists (PN 200/110, D888 and diltiazem).

X H Gu1, J J Liu, J S Dillon, W G Nayler.   

Abstract

The effect of endothelin, a potent vasoconstrictor polypeptide, on three types of calcium antagonist binding sites was examined, in rat cardiac membrane fragments. Endothelin 10 nM affected neither the affinity nor density of dihydropyridine binding sites. At concentrations of 10(-12)-10(-7) M, endothelin failed to displace bound (+)-[3H]-PN 200/110, (-)-[3H]-D888 and (+)-cis-[3H]-diltiazem. These results suggest that the calcium antagonist binding sites associated with L-type calcium channels are not the primary site of action of endothelin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2538185      PMCID: PMC1854350          DOI: 10.1111/j.1476-5381.1989.tb11811.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Assay for calcium channels.

Authors:  H Glossmann; D R Ferry
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

3.  Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto rats.

Authors:  Y Tomobe; T Miyauchi; A Saito; M Yanagisawa; S Kimura; K Goto; T Masaki
Journal:  Eur J Pharmacol       Date:  1988-08-02       Impact factor: 4.432

4.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

5.  Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and time.

Authors:  X H Gu; J S Dillon; W G Nayler
Journal:  J Cardiovasc Pharmacol       Date:  1988-09       Impact factor: 3.105

6.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

7.  A practical computer-based approach to the analysis of radioligand binding experiments.

Authors:  G A McPherson
Journal:  Comput Programs Biomed       Date:  1983 Aug-Oct

8.  Endothelial cells in culture produce a vasoconstrictor substance.

Authors:  R F O'Brien; R J Robbins; I F McMurtry
Journal:  J Cell Physiol       Date:  1987-08       Impact factor: 6.384

9.  Sustained coronary vasoconstriction provoked by a peptidergic substance released from endothelial cells in culture.

Authors:  M N Gillespie; J O Owasoyo; I F McMurtry; R F O'Brien
Journal:  J Pharmacol Exp Ther       Date:  1986-02       Impact factor: 4.030

  9 in total
  10 in total

1.  Nifedipine and experimental cardioprotection.

Authors:  W G Nayler; J J Liu; S Panagiotopoulos
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Endothelin: a review of its effects and possible mechanisms of action.

Authors:  W Lovenberg; R C Miller
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

3.  Inability of endothelin to increase Ca2+ current in guinea-pig heart cells.

Authors:  N Tohse; Y Hattori; H Nakaya; M Endou; M Kanno
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

4.  Endothelin binding to cultured calf adrenal zona glomerulosa cells and stimulation of aldosterone secretion.

Authors:  E N Cozza; C E Gomez-Sanchez; M F Foecking; S Chiou
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

5.  Mechanism of endothelin-induced contraction in guinea-pig trachea: comparison with rat aorta.

Authors:  D W Hay
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

6.  The pharmacological properties of the peptide, endothelin.

Authors:  R M Eglen; A D Michel; N A Sharif; S R Swank; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

7.  Endothelin-1 inhibits PAF-induced paw oedema and pleurisy in the mouse.

Authors:  M G Henriques; G A Rae; R S Cordeiro; T J Williams
Journal:  Br J Pharmacol       Date:  1992-07       Impact factor: 8.739

8.  Potentiation by endothelin-1 of 5-hydroxytryptamine-induced contraction in coronary artery of the pig.

Authors:  K Nakayama; Y Ishigai; H Uchida; Y Tanaka
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

9.  Interaction between endothelin and vasodilators in the human internal mammary artery.

Authors:  G W He; C Q Yang; M J Mack; T E Acuff; W H Ryan; A Starr
Journal:  Br J Clin Pharmacol       Date:  1994-12       Impact factor: 4.335

10.  Endothelin-1 inhibits pre-stimulated tracheal submucosal gland secretion and epithelial albumin transport.

Authors:  E Yurdakos; S E Webber
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.